Kirk Taylor

Background

About Kirk Taylor

As an accomplished medical and strategic leader, I have held high-profile roles within state government, pharmaceutical, biotech, and disruptive startup companies. Combined with my clinical knowledge, I apply my entrepreneurial vision to drive access to start up and established companies, innovating biomanufacturing, medtech and drug development. I have also led nascent startup companies to secure seed funding (Series A, B, and C) and execute initial public offerings. Known for being a confident and compelling communicator, I am asked to speak at internal meetings as well as industry conferences on Life Sciences, Health Care Policy, Private/Public Partnerships, Health Equity, Late Phase Development, and Real World Evidence. I have a demonstrated history of empowering and inspiring teams to perform to their fullest potential. People are a team's greatest asset. A neurologist by training, I have devoted my career to advancing technologies and therapies that address unmet medical need, improve patient outcomes and deliver on revenue and profitability goals. After serving as CMO for Brainstorm Cell Therapeutics, an ALS company, I was appointed by the Governor of Massachusetts to be the President and CEO of the Massachusetts Life Sciences Center, the #1 Life Sciences hub in the nation. Some of the critical accomplishments of my career include the following: • Presented to the public with the Governor and Lieutenant Governor, regional and international partnerships pertaining to economic development in the life sciences• Launched 3 new treatments for oncology (Copiktra,Bavencio, Tepotinib), 4 in multiple sclerosis, Lyrica for pain and fibromyalgia, Relpax for migraine, and Macugen for AMD• Presented safety data at FDA Advisory Committee Meeting for NurOwn ALS NDA review • Executed the ASD Phase 1 program for asset CP101, including IND, protocol development, and contract research organization [CRO] selection at Finch Therapeutics.• Won the Pharmavoice 100 Executives Award for 2023 for Top 100 Pharma Executives in the US• Named to Boston Business Journal’s 2025 Power 50 Key Strategic and Operational Skills:Drug Development & CommercializationBudget Planning & Financial StewardshipGlobal Regulatory Processes & PracticesBoard Member & C- Suite EngagementCorporate Transformation and CultureNow seeking board, advisory and consulting positions, I am poised to help guide a growing organization to its next level of excellence. If you would like to connect for board, consulting, advisory or other opportunities, please contact me through LinkedIn.